Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil citrate for asymmetrical intrauterine growth restriction
PACTR201705002278236Recruiting
- Sponsor
- Ain Shams University
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sildenafil and aspirin in intrauterine growth restriction (IUGR) (2 arms), sponsored by Ain Shams University. Primary endpoint: Gain in fetal abdominal circumference. Started May 2017; status: recruiting.
02
Drugs
sildenafilaspirin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on PACTR201705002278236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201705002278236.